Literature DB >> 24240637

10-minute delayed recall from the modified mini-mental state test predicts Alzheimer's disease pathology.

Scott A Lyness1, Ae Young Lee2, Chris Zarow1, Evelyn L Teng1, Helena C Chui1.   

Abstract

We compared the sensitivity and specificity of two delayed recall scores from the Modified Mini-Mental State (3MS) test with consensus clinical diagnosis to differentiate cognitive impairment due to Alzheimer's disease (AD) versus non-AD pathologies. At a memory disorders clinic, 117 cognitively impaired patients were administered a baseline 3MS test and received a contemporaneous consensus clinical diagnosis. Their brains were examined after death about 5 years later. Using logistic regression with forward selection to predict pathologically defined AD versus non-AD, 10-min delayed recall entered first (p = 0.001), followed by clinical diagnosis (p = 0.02); 1-min delayed recall did not enter. 10-min delayed recall scores ≤4 (score range = 0-9) were 87% sensitive and 47% specific in predicting AD pathology; consensus clinical diagnosis was 82% sensitive and 45% specific. For the 57 patients whose initial Mini-Mental State Examination scores were ≥19 (the median), 3MS 10-min delayed recall scores ≤4 showed some loss of sensitivity (80%) but a substantial gain in specificity (77%). In conclusion, 10-min delayed recall score on the brief 3MS test distinguished between AD versus non-AD pathology about 5 years before death at least as well as consensus clinical diagnosis that requires much more comprehensive information and complex deliberation.

Entities:  

Keywords:  Autopsy; Modified Mini-Mental State (3MS); consensus; dementia; memory disorders; neuropsychological tests; sensitivity and specificity

Mesh:

Year:  2014        PMID: 24240637      PMCID: PMC4220788          DOI: 10.3233/JAD-130524

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  27 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

Review 2.  A review of screening tests for cognitive impairment.

Authors:  Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

3.  Forgetting in dementia with and without subcortical lacunes.

Authors:  Joel H Kramer; Dan Mungas; Bruce R Reed; Norbert Schuff; Michael W Weiner; Bruce L Miller; Helena C Chui
Journal:  Clin Neuropsychol       Date:  2004-02       Impact factor: 3.535

4.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

5.  Rate of forgetting in mild Alzheimer's-type dementia.

Authors:  R P Hart; J A Kwentus; S W Harkins; J R Taylor
Journal:  Brain Cogn       Date:  1988-02       Impact factor: 2.310

Review 6.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

7.  Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.

Authors:  Bruce R Reed; Dan M Mungas; Joel H Kramer; William Ellis; Harry V Vinters; Chris Zarow; William J Jagust; Helena C Chui
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

8.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Authors:  M L Kraybill; E B Larson; D W Tsuang; L Teri; W C McCormick; J D Bowen; W A Kukull; J B Leverenz; M M Cherrier
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

9.  Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia.

Authors:  Murray Grossman; David J Libon; Mark S Forman; Lauren Massimo; Elisabeth Wood; Peachie Moore; Chivon Anderson; Jennifer Farmer; Anjan Chatterjee; Christopher M Clark; H Branch Coslett; Howard I Hurtig; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2007-11

10.  Canadian study of health and aging: study methods and prevalence of dementia.

Authors: 
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

View more
  4 in total

Review 1.  Early neuropsychological detection of Alzheimer's disease.

Authors:  C Bastin; E Salmon
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

2.  Frailty-a risk factor of global and domain-specific cognitive decline among a nationally representative sample of community-dwelling older adult U.S. Medicare beneficiaries.

Authors:  Nadia M Chu; Qian-Li Xue; Mara A McAdams-DeMarco; Michelle C Carlson; Karen Bandeen-Roche; Alden L Gross
Journal:  Age Ageing       Date:  2021-09-11       Impact factor: 12.782

3.  Grandchild Caregiving and Cognitive Health Among Grandparents in Rural South Africa.

Authors:  Elyse A Jennings; Meagan T Farrell; Lindsay C Kobayashi
Journal:  J Aging Health       Date:  2021-03-31

Review 4.  A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.

Authors:  Emma Lawrence; Carolin Vegvari; Alison Ower; Christoforos Hadjichrysanthou; Frank De Wolf; Roy M Anderson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.